title: Statins in pregnancy: new safety data are reassuring, but suspension of treatment is still advisable.
authors.affiliation: Bordeaux Regional Pharmacovigilance Centre, CHU de Bordeaux, France, INSERM U657, France francoise.haramburu@u-bordeaux.fr.
authors.forename: Françoise
authors.initials: F
authors.lastname: Haramburu
authors.affiliation: Bordeaux Regional Pharmacovigilance Centre, CHU de Bordeaux, France, INSERM U657, France.
authors.forename: Amélie
authors.initials: A
authors.lastname: Daveluy
authors.affiliation: Bordeaux Regional Pharmacovigilance Centre, CHU de Bordeaux, France, INSERM U657, France.
authors.forename: Ghada
authors.initials: G
authors.lastname: Miremont-Salamé
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D011247:Pregnancy
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors